Paper10697522
De novo deletions of p53 gene and wild-type p53 correlate with acquired cisplatin-resistance in human osteosarcoma OST cell line.
Asada N and 2 others. Anticancer Res, 1999. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. De novo deletions of p53 gene and wild-type p53 correlate with acquired cisplatin-resistance in human osteosarcoma OST cell line. Papers, record 10697522. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10697522
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- De novo deletions of p53 gene and wild-type p53 correlate with acquired cisplatin-resistance in human osteosarcoma OST cell line.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Cisplatin | Major topic |
| Gene Deletion | Major topic |
| Genes, p53 | Major topic |
| Osteosarcoma | Major topic |
| Base Sequence | |
| Chromosomes, Human, Pair 17 | |
| DNA Primers | |
| Drug Resistance, Neoplasm | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Tumor Cells, Cultured |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38807682 | Lymph node myeloid sarcoma with TP53‑associated myelodysplastic syndrome: A case report. | Oncol Lett | 2024 | https://conductscience.org/library/papers/38807682 | PubMed |
| 35806218 | The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35806218 | PubMed |
| 34608255 | Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancer. | Sci Rep | 2021 | https://conductscience.org/library/papers/34608255 | PubMed |
| 33567616 | Mechanisms of Resistance to Conventional Therapies for Osteosarcoma. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33567616 | PubMed |
| 32961800 | Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32961800 | PubMed |
| 32854207 | Back to the Future: Rethinking the Great Potential of lncRNAS for Optimizing Chemotherapeutic Response in Ovarian Cancer. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32854207 | PubMed |
| 31322224 | Inhibition of MCM2 enhances the sensitivity of ovarian cancer cell to carboplatin. | Mol Med Rep | 2019 | https://conductscience.org/library/papers/31322224 | PubMed |
| 31276706 | TP53 in bone and soft tissue sarcomas. | Pharmacol Ther | 2019 | https://conductscience.org/library/papers/31276706 | PubMed |
| 29881292 | Emerging role of long non-coding RNAs in cisplatin resistance. | Onco Targets Ther | 2018 | https://conductscience.org/library/papers/29881292 | PubMed |
| 29535628 | Molecular Determinants of Sensitivity or Resistance of Cancer Cells Toward Sanguinarine. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/29535628 | PubMed |
| 28103585 | Long non-coding RNAs in osteosarcoma. | Oncotarget | 2017 | https://conductscience.org/library/papers/28103585 | PubMed |
| 26464619 | Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis. | Int J Clin Exp Pathol | 2015 | https://conductscience.org/library/papers/26464619 | PubMed |
| 24765137 | Molecular mechanisms of chemoresistance in osteosarcoma (Review). | Oncol Lett | 2014 | https://conductscience.org/library/papers/24765137 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10697522
GET https://conductscience.org/api/papers/v1/10697522/authors